HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-HT1B agonists induce anorexia at a postsynaptic site.

Abstract
Ru 24969 and two other putative 5-HT1B agonists 1-(3-chlorophenyl)piperazine (mCPP) and 1-[3-(trifluoromethyl) phenyl]piperazine (TFMPP) and RU 24969 dose-dependently decreased food intake over 4 h (and in the case of RU 24969 also over 24 h) in free-feeding male Sprague-Dawley rats. Decreasing the doses of the agonists below the range eliciting anorexia did not cause hyperphagia. The anorexic effect of RU 24969 over 4 h was antagonised by metergoline, (-)pindolol and (+/-)cyanopindolol, but not by ketanserin, spiperone or haloperidol. Metergoline and (+/-)cyanopindolol also antagonised the anorexic effect of RU 24969 over 24 h. This data is consistent with an action mediated by 5-HT1B receptors. Locomotor activity induced by RU 24969 was markedly antagonised by haloperidol despite its lack of effect on the anorexic response. Persistence of the anorexic effect of RU 24969 after p-chlorophenylalanine (pCPA) pretreatment suggests that 5-HT1B agonists induce anorexia at a postsynaptic 5-HT receptor.
AuthorsG A Kennett, C T Dourish, G Curzon
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 141 Issue 3 Pg. 429-35 (Sep 23 1987) ISSN: 0014-2999 [Print] Netherlands
PMID3666036 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Appetite Depressants
  • Indoles
  • Piperazines
  • Receptors, Serotonin
  • 1-(3-trifluoromethylphenyl)piperazine
  • 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole
  • Ketanserin
  • Haloperidol
  • 1-(3-chlorophenyl)piperazine
Topics
  • Animals
  • Appetite Depressants (pharmacology)
  • Haloperidol (pharmacology)
  • Indoles (pharmacology)
  • Ketanserin (pharmacology)
  • Male
  • Motor Activity (drug effects)
  • Piperazines (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin (drug effects, physiology)
  • Synapses (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: